A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma

Objective. This study is aimed at using genes related to the peroxisome proliferator-activated receptor (PPAR) pathway to establish a prognostic risk model in kidney renal clear cell carcinoma (KIRC). Methods. For this study, we first found the PPAR pathway-related genes on the gene set enrichment a...

Full description

Saved in:
Bibliographic Details
Main Authors: Yingkun Xu, Xiunan Li, Yuqing Han, Zilong Wang, Chenglin Han, Ningke Ruan, Jianyi Li, Xiao Yu, Qinghua Xia, Guangzhen Wu
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:PPAR Research
Online Access:http://dx.doi.org/10.1155/2020/6937475
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546955610292224
author Yingkun Xu
Xiunan Li
Yuqing Han
Zilong Wang
Chenglin Han
Ningke Ruan
Jianyi Li
Xiao Yu
Qinghua Xia
Guangzhen Wu
author_facet Yingkun Xu
Xiunan Li
Yuqing Han
Zilong Wang
Chenglin Han
Ningke Ruan
Jianyi Li
Xiao Yu
Qinghua Xia
Guangzhen Wu
author_sort Yingkun Xu
collection DOAJ
description Objective. This study is aimed at using genes related to the peroxisome proliferator-activated receptor (PPAR) pathway to establish a prognostic risk model in kidney renal clear cell carcinoma (KIRC). Methods. For this study, we first found the PPAR pathway-related genes on the gene set enrichment analysis (GSEA) website and found the KIRC mRNA expression data and clinical data through TCGA database. Subsequently, we used R language and multiple R language expansion packages to analyze the expression, hazard ratio analysis, and coexpression analysis of PPAR pathway-related genes in KIRC. Afterward, using the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) website, we established the protein-protein interaction (PPI) network of genes related to the PPAR pathway. After that, we used LASSO regression curve analysis to establish a prognostic survival model in KIRC. Finally, based on the model, we conducted correlation analysis of the clinicopathological characteristics, univariate analysis, and multivariate analysis. Results. We found that most of the genes related to the PPAR pathway had different degrees of expression differences in KIRC. Among them, the high expression of 27 genes is related to low survival rate of KIRC patients, and the high expression of 13 other genes is related to their high survival rate. Most importantly, we used 13 of these genes successfully to establish a risk model that could accurately predict patients’ prognosis. There is a clear correlation between this model and metastasis, tumor, stage, grade, and fustat. Conclusions. To the best of our knowledge, this is the first study to analyze the entire PPAR pathway in KIRC in detail and successfully establish a risk model for patient prognosis. We believe that our research can provide valuable data for future researchers and clinicians.
format Article
id doaj-art-8122e8725e204333851344f53eecdca2
institution Kabale University
issn 1687-4757
1687-4765
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series PPAR Research
spelling doaj-art-8122e8725e204333851344f53eecdca22025-02-03T06:46:29ZengWileyPPAR Research1687-47571687-47652020-01-01202010.1155/2020/69374756937475A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell CarcinomaYingkun Xu0Xiunan Li1Yuqing Han2Zilong Wang3Chenglin Han4Ningke Ruan5Jianyi Li6Xiao Yu7Qinghua Xia8Guangzhen Wu9Department of Urology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, ChinaDepartment of Urology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, ChinaDepartment of Radiology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, ChinaDepartment of Urology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, ChinaDepartment of Urology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, ChinaThe Nursing College of Zhengzhou University, Zhengzhou, Henan 450001, ChinaDepartment of Urology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, ChinaDepartment of Urology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, ChinaDepartment of Urology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, ChinaDepartment of Urology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, ChinaObjective. This study is aimed at using genes related to the peroxisome proliferator-activated receptor (PPAR) pathway to establish a prognostic risk model in kidney renal clear cell carcinoma (KIRC). Methods. For this study, we first found the PPAR pathway-related genes on the gene set enrichment analysis (GSEA) website and found the KIRC mRNA expression data and clinical data through TCGA database. Subsequently, we used R language and multiple R language expansion packages to analyze the expression, hazard ratio analysis, and coexpression analysis of PPAR pathway-related genes in KIRC. Afterward, using the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) website, we established the protein-protein interaction (PPI) network of genes related to the PPAR pathway. After that, we used LASSO regression curve analysis to establish a prognostic survival model in KIRC. Finally, based on the model, we conducted correlation analysis of the clinicopathological characteristics, univariate analysis, and multivariate analysis. Results. We found that most of the genes related to the PPAR pathway had different degrees of expression differences in KIRC. Among them, the high expression of 27 genes is related to low survival rate of KIRC patients, and the high expression of 13 other genes is related to their high survival rate. Most importantly, we used 13 of these genes successfully to establish a risk model that could accurately predict patients’ prognosis. There is a clear correlation between this model and metastasis, tumor, stage, grade, and fustat. Conclusions. To the best of our knowledge, this is the first study to analyze the entire PPAR pathway in KIRC in detail and successfully establish a risk model for patient prognosis. We believe that our research can provide valuable data for future researchers and clinicians.http://dx.doi.org/10.1155/2020/6937475
spellingShingle Yingkun Xu
Xiunan Li
Yuqing Han
Zilong Wang
Chenglin Han
Ningke Ruan
Jianyi Li
Xiao Yu
Qinghua Xia
Guangzhen Wu
A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma
PPAR Research
title A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma
title_full A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma
title_fullStr A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma
title_full_unstemmed A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma
title_short A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma
title_sort new prognostic risk model based on ppar pathway related genes in kidney renal clear cell carcinoma
url http://dx.doi.org/10.1155/2020/6937475
work_keys_str_mv AT yingkunxu anewprognosticriskmodelbasedonpparpathwayrelatedgenesinkidneyrenalclearcellcarcinoma
AT xiunanli anewprognosticriskmodelbasedonpparpathwayrelatedgenesinkidneyrenalclearcellcarcinoma
AT yuqinghan anewprognosticriskmodelbasedonpparpathwayrelatedgenesinkidneyrenalclearcellcarcinoma
AT zilongwang anewprognosticriskmodelbasedonpparpathwayrelatedgenesinkidneyrenalclearcellcarcinoma
AT chenglinhan anewprognosticriskmodelbasedonpparpathwayrelatedgenesinkidneyrenalclearcellcarcinoma
AT ningkeruan anewprognosticriskmodelbasedonpparpathwayrelatedgenesinkidneyrenalclearcellcarcinoma
AT jianyili anewprognosticriskmodelbasedonpparpathwayrelatedgenesinkidneyrenalclearcellcarcinoma
AT xiaoyu anewprognosticriskmodelbasedonpparpathwayrelatedgenesinkidneyrenalclearcellcarcinoma
AT qinghuaxia anewprognosticriskmodelbasedonpparpathwayrelatedgenesinkidneyrenalclearcellcarcinoma
AT guangzhenwu anewprognosticriskmodelbasedonpparpathwayrelatedgenesinkidneyrenalclearcellcarcinoma
AT yingkunxu newprognosticriskmodelbasedonpparpathwayrelatedgenesinkidneyrenalclearcellcarcinoma
AT xiunanli newprognosticriskmodelbasedonpparpathwayrelatedgenesinkidneyrenalclearcellcarcinoma
AT yuqinghan newprognosticriskmodelbasedonpparpathwayrelatedgenesinkidneyrenalclearcellcarcinoma
AT zilongwang newprognosticriskmodelbasedonpparpathwayrelatedgenesinkidneyrenalclearcellcarcinoma
AT chenglinhan newprognosticriskmodelbasedonpparpathwayrelatedgenesinkidneyrenalclearcellcarcinoma
AT ningkeruan newprognosticriskmodelbasedonpparpathwayrelatedgenesinkidneyrenalclearcellcarcinoma
AT jianyili newprognosticriskmodelbasedonpparpathwayrelatedgenesinkidneyrenalclearcellcarcinoma
AT xiaoyu newprognosticriskmodelbasedonpparpathwayrelatedgenesinkidneyrenalclearcellcarcinoma
AT qinghuaxia newprognosticriskmodelbasedonpparpathwayrelatedgenesinkidneyrenalclearcellcarcinoma
AT guangzhenwu newprognosticriskmodelbasedonpparpathwayrelatedgenesinkidneyrenalclearcellcarcinoma